These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

258 related items for PubMed ID: 21546932

  • 1. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis.
    Brown ML, Bonomi L, Ungerleider N, Zina J, Kimura F, Mukherjee A, Sidis Y, Schneyer A.
    Obesity (Silver Spring); 2011 Oct; 19(10):1940-9. PubMed ID: 21546932
    [Abstract] [Full Text] [Related]

  • 2. FSTL3 deletion reveals roles for TGF-beta family ligands in glucose and fat homeostasis in adults.
    Mukherjee A, Sidis Y, Mahan A, Raher MJ, Xia Y, Rosen ED, Bloch KD, Thomas MK, Schneyer AL.
    Proc Natl Acad Sci U S A; 2007 Jan 23; 104(4):1348-53. PubMed ID: 17229845
    [Abstract] [Full Text] [Related]

  • 3. Over-expression of Follistatin-like 3 attenuates fat accumulation and improves insulin sensitivity in mice.
    Brandt C, Hansen RH, Hansen JB, Olsen CH, Galle P, Mandrup-Poulsen T, Gehl J, Pedersen BK, Hojman P.
    Metabolism; 2015 Feb 23; 64(2):283-95. PubMed ID: 25456456
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Mechanisms involved in follistatin-induced hypertrophy and increased insulin action in skeletal muscle.
    Han X, Møller LLV, De Groote E, Bojsen-Møller KN, Davey J, Henríquez-Olguin C, Li Z, Knudsen JR, Jensen TE, Madsbad S, Gregorevic P, Richter EA, Sylow L.
    J Cachexia Sarcopenia Muscle; 2019 Dec 23; 10(6):1241-1257. PubMed ID: 31402604
    [Abstract] [Full Text] [Related]

  • 9. FSTL3-Neutralizing Antibodies Enhance Glucose-Responsive Insulin Secretion in Dysfunctional Male Mouse and Human Islets.
    Brown ML, Lopez A, Meyer N, Richter A, Thompson TB.
    Endocrinology; 2021 Oct 01; 162(10):. PubMed ID: 33539535
    [Abstract] [Full Text] [Related]

  • 10. Overexpression of follistatin-like 3 in gonads causes defects in gonadal development and function in transgenic mice.
    Xia Y, Sidis Y, Schneyer A.
    Mol Endocrinol; 2004 Apr 01; 18(4):979-94. PubMed ID: 14739256
    [Abstract] [Full Text] [Related]

  • 11. Growth differentiation factor 9 (GDF9) suppresses follistatin and follistatin-like 3 production in human granulosa-lutein cells.
    Shi FT, Cheung AP, Huang HF, Leung PC.
    PLoS One; 2011 Apr 01; 6(8):e22866. PubMed ID: 21829661
    [Abstract] [Full Text] [Related]

  • 12. Disruption of the sugar-sensing receptor T1R2 attenuates metabolic derangements associated with diet-induced obesity.
    Smith KR, Hussain T, Karimian Azari E, Steiner JL, Ayala JE, Pratley RE, Kyriazis GA.
    Am J Physiol Endocrinol Metab; 2016 Apr 15; 310(8):E688-E698. PubMed ID: 26884387
    [Abstract] [Full Text] [Related]

  • 13. Increased activin bioavailability enhances hepatic insulin sensitivity while inducing hepatic steatosis in male mice.
    Ungerleider NA, Bonomi LM, Brown ML, Schneyer AL.
    Endocrinology; 2013 Jun 15; 154(6):2025-33. PubMed ID: 23533219
    [Abstract] [Full Text] [Related]

  • 14. Characterization of follistatin-type domains and their contribution to myostatin and activin A antagonism.
    Cash JN, Angerman EB, Keutmann HT, Thompson TB.
    Mol Endocrinol; 2012 Jul 15; 26(7):1167-78. PubMed ID: 22593183
    [Abstract] [Full Text] [Related]

  • 15. Heparin and activin-binding determinants in follistatin and FSTL3.
    Sidis Y, Schneyer AL, Keutmann HT.
    Endocrinology; 2005 Jan 15; 146(1):130-6. PubMed ID: 15471966
    [Abstract] [Full Text] [Related]

  • 16. Circulating Follistatin and Activin A and Their Regulation by Insulin in Obesity and Type 2 Diabetes.
    Sylow L, Vind BF, Kruse R, Møller PM, Wojtaszewski JFP, Richter EA, Højlund K.
    J Clin Endocrinol Metab; 2020 May 01; 105(5):. PubMed ID: 32112102
    [Abstract] [Full Text] [Related]

  • 17. Differential synthesis and action of TGFß superfamily ligands in mouse and rat islets.
    Brown ML, Kimura F, Bonomi LM, Ungerleider NA, Schneyer AL.
    Islets; 2011 May 01; 3(6):367-75. PubMed ID: 21964310
    [Abstract] [Full Text] [Related]

  • 18. Myostatin, activin receptor IIb, and follistatin-like-3 gene expression are altered in adipose tissue and skeletal muscle of obese mice.
    Allen DL, Cleary AS, Speaker KJ, Lindsay SF, Uyenishi J, Reed JM, Madden MC, Mehan RS.
    Am J Physiol Endocrinol Metab; 2008 May 01; 294(5):E918-27. PubMed ID: 18334608
    [Abstract] [Full Text] [Related]

  • 19. Reduced Socs3 expression in adipose tissue protects female mice against obesity-induced insulin resistance.
    Palanivel R, Fullerton MD, Galic S, Honeyman J, Hewitt KA, Jorgensen SB, Steinberg GR.
    Diabetologia; 2012 Nov 01; 55(11):3083-93. PubMed ID: 22872213
    [Abstract] [Full Text] [Related]

  • 20. Follistatins in glucose regulation in healthy and obese individuals.
    Perakakis N, Kokkinos A, Peradze N, Tentolouris N, Ghaly W, Tsilingiris D, Alexandrou A, Mantzoros CS.
    Diabetes Obes Metab; 2019 Mar 01; 21(3):683-690. PubMed ID: 30393997
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.